From: Recent advances in nanomedicines for regulation of macrophages in wound healing
Type of nanoparticles | Payload | In vitro/in vivo model | Pathways | Therapeutic strategies | References |
---|---|---|---|---|---|
Drug-free inorganic nanomaterials induce macrophage polarization | |||||
 BGNPs | – | In vivo | Decreasing the inflammatory cytokines and increasing the secretion of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [116] |
 BGNPs | – | In vivo | Macrophage proliferation and polarization toward M2 phenotype to facilitate wound closure and re-epithelialization in diabetic wounds | Polarization of M1 to M2 phenotype | [117] |
 Gold-mesoporous BGNPs | – | In vivo | Decreasing the inflammatory cytokines and increasing the secretion of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [118] |
 Ceria nanocrystals decorated MSNPs | – | In vivo | Reducing ROS, differentiation of monocytes to macrophages, and modulation of anti-inflammatory factors | Polarization of M1 to M2 phenotype | [119] |
Drug-free organic nanomaterials induce macrophage polarization | |||||
 Nanofibrous scaffolds including copolymer of poly(lactide-co-caprolactone) and heart decellularized ECM | – | In vivo | Collagen deposition and decreasing the inflammatory cytokines and increasing the secretion of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [122] |
 Thioether grafted hyaluronic acid nanofibrous | – | In vivo | Decreasing the inflammatory cytokines and increasing the secretion of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [123] |
 Coaxial nanofibers of PLGA/fibrinogen and PLGA/collagen | – | In vivo | Promotion of the secretion of immunosuppressive factors as well as wound healing growth factors | Polarization of M1 to M2 phenotype | [124] |
 α-Gal epitope nanoparticles | – | In vivo | Decreasing the inflammatory cytokines and increasing the secretion of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [125] |
 Supramolecular peptide hydrogel nanoparticles | – | In vitro | Reduction of NO and decreasing the inflammatory cytokines and increasing the secretion of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [126] |
 Amphiphilic galactomannan nanoparticles | – | In vivo | Decreasing the inflammatory cytokines and increasing the secretion of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [127] |
Drug-free organic–inorganic hybrid nanomaterials induce macrophage polarization | |||||
 Metallic AgNPs–collagen/chitosan scaffold | – | In vivo | Promotion of the inflammatory cytokines and increasing the secretion of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [130] |
 Magnesium particles embedded in electrospun PCL nanofibers | – | In vivo | Collagen deposition and decreasing the inflammatory cytokines and increasing the secretion of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [131] |
 SiO2 nanoparticles were modified by konjac glucomannan | – | In vivo | Collagen deposition and decreasing the inflammatory cytokines and increasing the secretion of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [132] |
 AgNPs was decorated with zwitterionic poly(carboxybetaine-co-dopamine methacrylamide) copolymer | – | In vivo | Acceleration of the migration of fibroblast cells, factors for pro-inflammatory level increased as well as markers for macrophage activity | Polarization of M1 to M2 phenotype | [133] |
 Inorganic/organic hybrid nanocomposites of silver/talc nanoparticles coated with chitosan | – | In vivo | Increasing vascularization and angiogenesis, collagen deposition and decreasing the inflammatory cytokines and increasing the secretion of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [134] |
 Gold/perlite mesoporous nanocomposites coated with chitosan | – | In vivo | Decreasing the inflammatory cytokines and increasing the secretion of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [135] |
 Magnesium-containing BGNPs incorporated with hyaluronic acid and quaternized chitosan hydrogels | – | In vivo | Increasing vascularization and angiogenesis, collagen deposition and decreasing the inflammatory cytokines and increasing the secretion of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [136] |
Drug-loaded inorganic nanomaterials induce macrophage polarization | |||||
 AgNPs | Tannic acid | In vivo | Promotion of epithelialization, angiogenesis, and granulation tissue by increasing the expression of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [137] |
 Super paramagnetic iron oxide nanoparticles | Heparin bonded fibroblast growth factor | In vivo | Controlled release of fibroblast growth factor. Granulation formation and collagen deposition due to the promotion of cell proliferation and M2 phenotype polarization | Polarization of M1 to M2 phenotype | [138] |
 AuNPs | Snail mucus (Helix Aspersa) | In vitro | Reduction of LPS induced IL-6 and IL-1ꞵ cytokine levels and elimination of iNOS synthesis | Depletion of M1 phenotype | [139] |
Drug-loaded organic nanomaterials induce macrophage polarization | |||||
 Silk nanofiber | Asiaticoside | In vivo | Regulation of inflammatory reaction and vascularization | Polarization of M1 to M2 phenotype | [140] |
 Hyaluronic acid nanoparticles | miR-223 | In vivo | Increasing anti-inflammatory gene and decreasing pro-inflammatory markers | Polarization of M1 to M2 phenotype | [141] |
 Phenyl boronic acid-modified alginate nanocapsules | Amikacin and naproxen | In vivo | Decreasing the inflammatory cytokines and increasing the secretion of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [142] |
 Membrane with nanotopography of dihydroxyterephthaldehyde and 5,10,15,20-(tetra-4-aminophenyl)porphyrin | Ibuprofen | In vivo | Reducing the inflammatory reaction of macrophages and increasing the proportion of M2 macrophages at the injury site | Polarization of M1 to M2 phenotype | [143] |
 Phosphatidylserine-nanoliposomes | Apoptotic cell | In vivo | Increasing the related cytokines to M2 macrophages, expression of the vascular endothelial marker CD31and accelerate wound closure | Polarization of M1 to M2 phenotype | [144] |
Drug-loaded organic–inorganic hybrid nanomaterials induce macrophage polarization | |||||
 MSNPs coated with collagen | Gentamicin and rifamycin | In vivo | Decreasing the inflammatory cytokines and increasing the secretion of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [147] |
 Mesoporous silica coated AgNPs in poloxamer hydrogel | Gentamicin | In vivo | decreasing the related cytokines to M1 macrophages, expression of the marker CD86 and accelerate diabetic wound healing | Depletion of M1 phenotype | [148] |
 MSNPs coated with cellulose acetate | Econazole nitrate and triamcinolone acetonide | In vivo | Decreasing the inflammatory cytokines and increasing the secretion of anti-inflammatory cytokines | Polarization of M1 to M2 phenotype | [149] |